Oncology & Cancer

A new approach to targeting cancer cells

A University of California, Riverside, research team has come up with a new approach to targeting cancer cells that circumvents a challenge faced by currently available cancer drugs.

Oncology & Cancer

'Lock-'n'-block' drug may prevent cancer from metastasizing

"They got all of it" are the reassuring words people hope to hear following cancer surgery, but a growing understanding of the science of how cancer spreads, and metastasizes, is suggesting that not only is this almost never ...

Oncology & Cancer

Researchers identify neurotransmitter that helps cancers progress

Using human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotransmitter in the spread of aggressive cancers. Neurotransmitters are chemical ...

Oncology & Cancer

New cancer drug targets accelerate path to precision medicine

In one of the largest studies of its kind, researchers used CRISPR technology to disrupt every gene in over 300 cancer models from 30 cancer types and discover thousands of key genes essential for cancer's survival. The team, ...

Oncology & Cancer

Scientists compare methods of drug delivery to malignant tumors

A team of biologists from Sechenov First Moscow State Medical University and Lobachevsky University (Nizhny Novgorod) has analyzed available methods of targeted drug delivery to malignant tumors. Individual approaches to ...

Oncology & Cancer

Starving leukemia cells by targeting amino acids

Cancer cells consume sugar at a higher rate than healthy cells, but they're also hungry for amino acids, the building blocks of proteins and other biomolecules. Researchers at Winship Cancer Institute of Emory University ...

Immunology

Venoms are sources in the search for new medicines

Animal venoms are the subject of study at the Butantan Institute in São Paulo. But in this case, the idea is not to find antidotes, but rather to use the properties of the venoms themselves to identify molecular targets ...

Obstetrics & gynaecology

Folliculin mutations disrupt embryo implantation

New information is unfolding on the genetic controls of an early turning point in pregnancy. As the tiny, dividing cell mass, the blastocyst, travels from the oviduct and lodges in the wall of the uterus, the cells must exit ...

page 1 from 23